E018 Characterising the earliest neurodegenerative changes in HD: multi-modal neuroimaging insights from the Huntington’s disease young adult study (HD-YAS)
<h3>Background</h3> HD-YAS aims to characterise the HD phenotype ~24 years from predicted disease onset in a unique cohort of gene expansion carriers (GECs), evaluated at two time-points ~4.5 years apart. <h3>Aims</h3> To characterise the earliest neurodegenerative changes with multi-modal MRI. <h3>Methods</h3> 154 participants were recruited: 131 at visit 1 (64 GECs, 67 controls) and 23 additional participants at visit 2 (9 GECs, 14 controls). >90% of participants underwent 3T MRI, providing volume/atrophy, diffusion, structural-connectivity, and quantitative-MRI (multi-parameter mapping (MPMs)) metrics. These were assessed cross-sectionally over pre-defined regions-of-interest, using all datapoints and mixed effect regression with random participant effect. Longitudinal direct change analyses used linear regression of a single change measure per participant. <h3>Results</h3> Volumetrics: Cross-sectionally, GECs showed reductions in whole-brain, grey-matter, white-matter, caudate and putamen volumes compared with controls, which were associated with age, CAG, or their interaction (FDR<0.15). Longitudinally, elevated atrophy rates were evident in all regions-of-interest (FDR<0.02), and most prominent in the caudate and putamen (FDR<1.2x10–9); rates were influenced by age, CAG or their interaction (FDR<1.5x10–2). MPMs: Cross-sectionally, R1 was elevated in the putamen in GECs compared with controls (FDR=0.1); and associated with age and CAG (FDR=0.1), suggestive of increased iron levels. There was no evidence of differences in metrics sensitive to demyelination. There were no significant longitudinal findings. Structural connectivity: No significant findings. <h3>Conclusions</h3> Elevated atrophy rates, particularly striatal, are evident >20 years prior to predicted symptom onset. Increased iron in the putamen may be a very early feature. Together with the absence of congruent myelin-contrast decreases, this is suggestive of increased levels of toxicity and neuronal loss.
Authors
- Rachael I. Scahill (ORCID: https://orcid.org/0000-0002-1832-106X)
- Douglas R. Langbehn (ORCID: https://orcid.org/0000-0002-7803-4679)
- Edward J. Wild (ORCID: https://orcid.org/0000-0002-6921-7887)
- Kate Fayer (ORCID: https://orcid.org/0000-0002-4198-2632)
- Michela Leocadi (ORCID: https://orcid.org/0000-0001-7321-6054)
- Sarah J. Tabrizi (ORCID: https://orcid.org/0000-0003-2716-2045)
- Mena S. Farag (ORCID: https://orcid.org/0000-0002-0679-0117)
- Olivia Thackeray
- Hui Zhang (ORCID: https://orcid.org/0000-0002-5426-2140)
- Christopher S. Parker (ORCID: https://orcid.org/0000-0003-1879-0357)
- Michael Murphy (ORCID: https://orcid.org/0000-0001-8963-5747)
- Nicola Z. Hobbs
Institutions
- University of Iowa (US)
- National Hospital for Neurology and Neurosurgery (GB)
- University College London (GB)
Publication Details
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1136/jnnp-2024-ehdn.114
- Primary Topic
- Genetic Neurodegenerative Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00